s!AksNHQl9Vc2hqGfBEwJuOcj02L9Q?e=9xc8b0

https://docs.google.com/document/d/1IRMTATI8meF6E3oTTkDKpLjGeMRkNQg1XWu1D7JZX3c/edi

Zotero-Bibbase Library/Infranodus Re-Usable Blocks

The neuroscience–systems biology disconnect: towards the NeuroPhysiome - Morris - 2012 - Experimental Physiology - Wiley Online Library

Adobe Acrobat

JCM | Free Full-Text | MDMA for the Treatment of Negative Symptoms in Schizophrenia

Molecular Variants in Human Trace Amine-Associated Receptors and Their Implications in Mental and Metabolic Disorders

PhenoPredict

Precision Psychiatry Applications with Pharmacogenomics: Artificial Intelligence and Machine Learning Approaches

Controlling astrocyte-mediated synaptic pruning signals for schizophrenia drug repurposing with deep graph networks

An Early Stage Researcher’s Primer on Systems Medicine Terminology

Multidimensional Connectomics and Treatment-Resistant Schizophrenia: Linking Phenotypic Circuits to Targeted Therapeutics

OpenTrials: towards a collaborative open database of all available information on all clinical trials | Trials | Full Text

Beyond antipsychotics: a twenty-first century update for preclinical development of schizophrenia therapeutics

Trace Amine-Associated Receptor 1 as a Target for the Development of New Antipsychotics: Current Status of Research and Future Directions

The Promise of Psychedelic Science

Evolving Concepts of the Schizophrenia Spectrum: A Research Domain Criteria Perspective

Integrative Omics for Informed Drug Repurposing: Targeting CNS Disorders

Combining phenome-driven drug-target interaction prediction with patients' electronic health records-based clinical corroboration toward drug discovery